Lung Cancer Awareness Month 2026: Exploring Precision Lung Cancer Treatment in St. Louis

Lung Cancer Awareness Month, observed each November, is a reminder of the importance of understanding lung cancer, recognizing potential symptoms, and learning about advances in cancer treatment. For patients and families throughout the St. Louis region, access to reliable information can make it easier to navigate a diagnosis and explore available care options.

At St. Louis CyberKnife, advanced robotic radiation technology offers a specialized approach to treating certain tumors without conventional surgery. The CyberKnife system combines image-guided technology, computerized treatment planning, and flexible robotic radiation delivery to help physicians target tumors with precision.

For appropriately selected patients with lung cancer, stereotactic body radiation therapy (SBRT) may offer a focused treatment option that can be completed in a limited number of sessions.

This November, take the opportunity to learn more about lung cancer, understand the role of radiation oncology, and discover the treatment resources available through St. Louis CyberKnife in Fenton, Missouri.

Lung Cancer: Risk Factors, Symptoms, and Awareness

Lung cancer develops when cells within the lungs begin growing abnormally and multiply without normal control. Although smoking is the leading risk factor, lung cancer can also develop in people who have never used tobacco.

Several factors may contribute to an increased risk of lung cancer:

• Tobacco smoke: Smoking and exposure to secondhand smoke are major risk factors.
• Radon exposure: This naturally occurring gas can accumulate inside homes and buildings, increasing risk over time.
• Environmental and occupational exposures: Asbestos, diesel exhaust, and certain workplace substances are associated with lung cancer.
• Family history: A family history of the disease may be relevant when assessing personal risk.
• Air pollution: Long-term exposure to polluted air has been linked to an increased risk of lung cancer.

Learning about these factors can help individuals make informed decisions about their health. Avoiding tobacco, limiting exposure to harmful substances, and discussing personal risk with a healthcare provider are useful steps toward prevention.

When Should You Seek Medical Evaluation?

Lung cancer can develop without obvious symptoms in its early stages. When symptoms do appear, they may include:

• A persistent or changing cough
• Blood in the sputum
• Shortness of breath
• Chest pain or discomfort
• Unexplained weight loss
• Ongoing fatigue or repeated respiratory infections

These symptoms may have causes unrelated to cancer, but persistent or worsening changes should be evaluated by a medical professional.

Patients should also discuss lung cancer screening with their healthcare provider. Screening and diagnostic evaluation serve different purposes: individuals experiencing concerning symptoms should seek medical assessment rather than wait for a screening appointment.

Early evaluation can help patients understand the cause of their symptoms and, when necessary, move forward with appropriate testing and treatment.

Understanding the CyberKnife System for Lung Tumors

Radiation therapy plays an important role in treating many cancers. Advances in treatment technology have made it possible to deliver radiation using increasingly sophisticated methods designed to target tumors while limiting exposure to surrounding healthy tissue.

The CyberKnife system is a robotic radiation delivery platform that directs carefully planned radiation beams toward a defined target from multiple angles. Its capabilities help clinicians account for changes in positioning and, when appropriate, movement associated with breathing.

Despite the name, the CyberKnife treatment does not involve a surgical blade or an incision. Radiation is delivered externally, making it a noninvasive option for selected tumors.

For certain patients with lung cancer, this technology can support SBRT, which uses highly focused radiation doses to treat the target over a relatively short course.

Whether this approach is suitable depends on the patient’s diagnosis, tumor characteristics, overall health, and treatment goals.

Three Ways the CyberKnife System Supports Precision Treatment

Lung tumors can be challenging to treat because they sit within a moving organ and may be close to sensitive structures. Treatment planning must account for these factors while delivering the prescribed radiation dose.

The CyberKnife system incorporates several features that help radiation oncology teams address these challenges.

1. Flexible Robotic Radiation Delivery

The system uses a robotic arm to position the radiation source at different angles around the patient. This flexibility allows clinicians to develop a treatment plan that directs radiation toward the tumor along multiple beam paths.

By carefully selecting those paths, the treatment team can concentrate the prescribed dose on the target while working to reduce unnecessary exposure to nearby healthy tissues.

This is especially relevant when treating tumors near critical structures in the chest. The specific treatment plan is designed around each patient’s anatomy and clinical circumstances.

2. Image Guidance and Respiratory Motion Management

The lungs move naturally during breathing, which means the position of a tumor can change during treatment.

The CyberKnife system uses image-guided tracking technology to help monitor the treatment target and account for relevant movement, depending on the tracking method and treatment plan being used.

These capabilities help the clinical team deliver radiation according to the planned target position rather than relying solely on an image captured before treatment begins.

The approach is intended to support accurate radiation delivery while accounting for the movement that makes lung treatment particularly complex.

3. Personalized, Focused Radiation Plans

No two patients have exactly the same treatment needs. Tumor size, location, cancer stage, previous treatment, and overall health all influence the approach recommended by the radiation oncologist.

Using diagnostic images and specialized planning software, the care team determines the target area, radiation dose, and delivery technique best suited to the patient’s situation.

The number of treatments varies, and a shorter schedule is not appropriate for every lung cancer diagnosis.

Who May Be a Candidate for CyberKnife Treatment?

The CyberKnife treatment system may be considered for selected patients whose treatment plan calls for highly targeted radiation. In lung cancer care, potential applications include several clinical situations.

Certain early-stage lung cancers

For patients with localized lung cancer, SBRT may be an option when surgery is not medically appropriate or when radiation is recommended as an alternative treatment.

Patients with other medical conditions

Some patients have health conditions that make surgery more complicated or increase its risks. A radiation oncologist can determine whether focused radiation is a suitable option based on the patient’s overall health and tumor characteristics.

Selected tumors that have returned or spread

In some circumstances, radiation can be used to treat a specific tumor site in patients with recurrent or metastatic disease. This decision depends on the extent of cancer, prior treatment, and broader treatment goals.

Cases requiring careful targeting

When a tumor is near important structures or moves with breathing, advanced imaging and treatment planning may help clinicians account for those factors when developing the radiation plan.

Other patients may benefit from surgery, conventional radiation therapy, chemotherapy, immunotherapy, targeted medications, or a combination of treatments.

A consultation with a radiation oncologist is essential to determine whether CyberKnife treatment is appropriate and how it compares with other options.

Your Path Through Radiation Treatment

Knowing what to expect can make the prospect of cancer treatment less intimidating. At St. Louis CyberKnife, the process begins with a clinical assessment to determine whether specialized radiation therapy may be appropriate.

Consultation and Review

The radiation oncologist evaluates the patient’s diagnosis, medical history, imaging studies, and previous treatments. This discussion helps establish the purpose of treatment and whether focused radiation may be beneficial.

Imaging and Treatment Design

If radiation is recommended, imaging helps define the tumor and surrounding anatomy. The treatment team uses specialized planning software to determine how radiation should be delivered and how nearby healthy structures can be protected as much as possible.

Preparation for Each Session

The patient is positioned on the treatment table, and the team follows the appropriate preparation and imaging procedures to support accurate targeting.

Radiation Delivery

During treatment, the robotic system moves around the patient to deliver radiation from planned angles. The procedure is noninvasive, and general anesthesia is typically unnecessary.

Follow-Up and Monitoring

After treatment, the care team provides recommendations for follow-up visits and imaging. Tumor response develops over time, so continued monitoring is important for evaluating the results and identifying potential complications.

Patients should discuss possible short-term and delayed side effects with their physician before beginning treatment.

Benefits and Considerations of Stereotactic Radiation Therapy

For appropriately selected patients, SBRT delivered with the CyberKnife system may offer several practical and clinical advantages.

• A noninvasive approach: Treatment is delivered from outside the body without surgical incisions.
• Targeted radiation delivery: Advanced imaging and planning help focus radiation on the intended tumor.
• Movement-aware treatment: Tracking capabilities help the team account for relevant changes in target position.
• Fewer visits for some patients: Certain treatment plans can be completed over a small number of sessions.
• Outpatient treatment: Patients generally do not need an overnight hospital stay for each radiation session.

However, precision does not eliminate the possibility of side effects. Patients may experience fatigue, irritation, discomfort, or inflammation depending on the location and dose of treatment.

For lung tumors, one potential complication is radiation pneumonitis, an inflammatory reaction in the lung that may develop after treatment. Its severity can vary, and patients should understand which symptoms warrant medical attention.

The radiation oncologist will discuss the expected benefits, possible risks, alternative therapies, and follow-up plan before treatment begins.

St. Louis CyberKnife: Specialized Care in the Greater St. Louis Area

Choosing a treatment center involves more than selecting a technology. Patients also need experienced clinicians, clear explanations, and an individualized plan that considers their medical needs and personal circumstances.

For people living in St. Louis County and the surrounding region, having access to specialized radiation treatment in Fenton may also reduce the burden of traveling farther from home for care.

Patients can contact the center to discuss consultation requirements, referrals, treatment evaluations, and whether the CyberKnife treatment system may be suitable for their particular diagnosis.

How to Make a Difference During Lung Cancer Awareness Month

Lung Cancer Awareness Month provides an opportunity to share reliable health information and support individuals and families affected by the disease.

Here are a few ways to take part this November:

1. Start a conversation about lung health. Encourage loved ones to speak with a healthcare professional about their risks and any concerning symptoms.
2. Understand screening recommendations. Ask a provider whether screening is appropriate based on age, smoking history, and other eligibility factors.
3. Learn about treatment choices. If lung cancer is diagnosed, ask about the potential roles of surgery, radiation, and medication-based therapies.
4. Be there for patients and caregivers. Offer transportation, help with everyday responsibilities, or emotional support during appointments and treatment.
5. Share trustworthy information. Direct friends and family to reputable medical resources instead of unverified treatment claims.

Awareness can help people take meaningful steps toward earlier evaluation, informed decision-making, and compassionate support for those affected by lung cancer.

Take the Next Step With St. Louis CyberKnife

Every lung cancer diagnosis requires an individualized assessment. Treatment decisions should reflect the cancer’s stage and location, the patient’s health, and the goals of care.

At St. Louis CyberKnife, patients can explore whether this approach may be appropriate for their diagnosis and learn how it compares with other treatment options. A second opinion can also help clarify the choices available after a cancer diagnosis.

This Lung Cancer Awareness Month, take time to learn about lung cancer and ask questions about the treatment options available to you.

If you or a loved one is considering radiation treatment for lung cancer, contact St. Louis CyberKnife to request a consultation. The team can help you understand the evaluation process and discuss whether the CyberKnife system may be an appropriate part of your care.